Cancer of the Breast: Conservation Surgery and Curative Radiation Therapy � Technique

2015 ◽  
pp. 181-194 ◽  
Author(s):  
Luther W. Brady ◽  
John M. Bedwinek ◽  
Arnold M. Markoe ◽  
Bizhan Micaily ◽  
Jeffrey I. Damsker ◽  
...  
Keyword(s):  
Radiation Therapy ◽  
Breast Conservation ◽  
Breast Conservation Surgery ◽  
Therapy Technique ◽  
Conservation Surgery

Experience with Reduction Mammaplasty following Breast Conservation Surgery and Radiation Therapy

1998 ◽  
Vol 102 (6) ◽  
pp. 1913-1916 ◽  
Author(s):  
Scott L. Spear ◽  
James Benjamin Burke ◽  
Douglas Forman ◽  
Rebeeca A. Zuurbier ◽  
Christine D. Berg
Keyword(s):  
Radiation Therapy ◽  
Reduction Mammaplasty ◽  
Breast Conservation ◽  
Breast Conservation Surgery ◽  
Conservation Surgery

scholarly journals Underuse of Radiation Therapy After Breast Conservation Surgery in Puerto Rico: A Puerto Rico Central Cancer Registry–Health Insurance Linkage Database Study

2018 ◽  
pp. 1-9
Author(s):  
William W. Chance ◽  
Karen J. Ortiz-Ortiz ◽  
Kai-Ping Liao ◽  
Diego E. Zavala Zegarra ◽  
Michael C. Stauder ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Puerto Rico ◽  
Radiation Therapy ◽  
Health Insurance ◽  
Invasive Breast Cancer ◽  
Breast Conservation ◽  
Breast Conservation Surgery ◽  
Conservation Surgery ◽  
To Receive ◽  
Central Cancer Registry

Purpose To identify rates of postoperative radiation therapy (RT) after breast conservation surgery (BCS) in women with stage I or II invasive breast cancer treated in Puerto Rico and to examine the sociodemographic and health services characteristics associated with variations in receipt of RT. Methods The Puerto Rico Central Cancer Registry–Health Insurance Linkage Database was used to identify patients diagnosed with invasive breast cancer between 2008 and 2012 in Puerto Rico. Claims codes identified the type of surgery and the use of RT. Logistic regression models were used to examine the independent association between sociodemographic and clinical covariates. Results Among women who received BCS as their primary definitive treatment, 64% received adjuvant RT. Significant predictors of RT after BCS included enrollment in Medicare (odds ratio [OR], 2.14; 95% CI, 1.46 to 3.13; P ≤ .01) and dual eligibility for Medicare and Medicaid (OR, 1.61; 95% CI, 1.14 to 2.27; P < .01). In addition, it was found that RT was more likely to have been received in certain geographic locations, including the Metro-North (OR, 2.20; 95% CI, 1.48 to 3.28; P < .01), North (OR, 1.78; 95% CI, 1.20 to 2.64; P < .01), West (OR, 4.04; 95% CI, 2.61 to 6.25; P < .01), and Southwest (OR, 2.79; 95% CI, 1.70 to 4.59; P < .01). Furthermore, patients with tumor size > 2.0 cm and ≤ 5.0 cm (OR, 0.61; 95% CI, 0.40 to 0.93; P = .02) and those with tumor size > 5.0 cm (OR, 0.37; 95% CI, 0.15 to 0.92; P = .03) were found to be significantly less likely to receive RT. Conclusion Underuse of RT after BCS was identified in Puerto Rico. Patients enrolled in Medicare and those who were dually eligible for Medicaid and Medicare were more likely to receive RT after BCS compared with patients with Medicaid alone. There were geographic variations in the receipt of RT on the island.

scholarly journals INCIDENCE OF BREAST LYMPHEDEMA AND PREDICTORS OF ITS DEVELOPMENT IN PATIENTS RECEIVING WHOLE BREAST RADIATION THERAPY AFTER BREAST-CONSERVATION SURGERY

Lymphology ◽  
2020 ◽  
Vol 52 (3) ◽  
Author(s):  
RG Ganju ◽  
G Savvides ◽  
S Korentager ◽  
MJ Ward ◽  
M TenNapel ◽  
...  
Keyword(s):  
Radiation Therapy ◽  
Breast Conservation ◽  
Breast Conservation Surgery ◽  
Common Finding ◽  
Adjuvant Radiation ◽  
Increased Risk ◽  
Conservation Surgery ◽  
Arm Lymphedema ◽  
Chi Square Analysis

One common adverse effect following breast-conservation surgery and adjuvant radiation is lymphedema. While lymphedema of the arm has been well-characterized, there has been less investigation into lymphedema of the breast. We sought to characterize rates of breast lymphedema (BLE) in women with early-stage breast cancer and identify potential predictors in its development. Two hundred and thirty consecutive patients treated with lumpectomy and adjuvant whole breast radiation therapy (WBRT) from January 2016 - June 2017 were included. All patients were seen in our lymphedema monitoring clinic for baseline and at least one follow-up lymphedema measurement. BLE grades were assigned by trained nurses in the lymphedema clinic. Data regarding patient demographic and treatment factors were extracted from the electronic medical record. Comparisons between groups were made using Chi-Square analysis performed in SAS. The median age of the sample was 62 (range 31-90). Median follow-up from surgery was 15.3 months. Forty-three patients were diagnosed with lymphedema of the breast (18.7%). Rates of grade 1 and 2 BLE were 93% and 7%, respectively; there were no cases of severe lymphedema. Sixty-three percent of cases resolved by last follow-up with treatment recommendations. There was no association between development of BLE and patient factors investigated, including age, T stage, radiation dose and fractionation, lymph node biopsy, number of lymph nodes removed, development of arm lymphedema, and use of chemotherapy. Tumor subtype was found to be significant (P = 0.04) and there was a trend towards significance for receipt of trastuzumab (P = 0.09). BLE is a distinct entity from arm lymphedema and is a common finding in women treated with breast-conserving surgery and adjuvant WBRT. It is a generally mild and self-limiting process. There were no treatment or patient-related factors that correlated with increased risk of lymphedema development in our sample except for HER-2 positive disease and receipt of trastuzamab.

scholarly journals Postmastectomy-Postirradiation Atypical Vascular Lesion of the Skin: Report of 2 Cases

2012 ◽  
Vol 2012 ◽  
pp. 1-4 ◽  
Author(s):  
P. S. Jayalakshmy ◽  
Aswathy P. Sivaram ◽  
Joy Augustine ◽  
P. Bindu
Keyword(s):  
Radiation Therapy ◽  
Causal Relationship ◽  
Chest Wall ◽  
Breast Conservation ◽  
Vascular Lesion ◽  
Breast Conservation Surgery ◽  
Vascular Lesions ◽  
Breast Parenchyma ◽  
Conservation Surgery ◽  
Poorly Differentiated

The spectrum of vascular lesions developing in breast or chest wall skin following lumpectomy or mastectomy and radiation is wide and ranges from atypical vascular lesions with a benign clinical behaviour to frankly malignant, angiosarcoma ranging histologically from well to poorly differentiated variety. Postmastectomy-postirradiation atypical vascular lesions (AVLs) are rare and develop in the skin adjacent to the mastectomy scar. About hundred cases have been reported in the literature so far. AVLs have also been reported in patients after breast conservation surgery within the breast parenchyma or in the skin around the scar. The incidence appears to be rising. The exact reason for this is not known. The newer modalities of radiation therapy may be contributory to the pathogenesis. More studies have to be done in this area to prove the causal relationship. We are reporting the cases of 2 patients with carcinoma of breast who developed postmastectomy-postirradiation atypical vascular lesions. The cases were received in our department within a 6-month period.

Impact of breast MRI in women eligible for breast conservation surgery and intra-operative radiation therapy

2018 ◽  
Vol 27 (1) ◽  
pp. 95-99 ◽  
Author(s):  
Nitika Paudel ◽  
Kevin P. Bethke ◽  
Lilian C. Wang ◽  
Jonathan B. Strauss ◽  
John P. Hayes ◽  
...  
Keyword(s):  
Radiation Therapy ◽  
Breast Conservation ◽  
Breast Mri ◽  
Breast Conservation Surgery ◽  
Conservation Surgery
Sign in / Sign up

Export Citation Format

Share Document